208 related articles for article (PubMed ID: 30822440)
1. Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues.
Walters DC; Arning E; Bottiglieri T; Jansen EEW; Salomons GS; Brown MN; Schmidt MA; Ainslie GR; Roullet JB; Gibson KM
Neurochem Int; 2019 May; 125():151-162. PubMed ID: 30822440
[TBL] [Abstract][Full Text] [Related]
2. Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.
Walters DC; Jansen EEW; Ainslie GR; Salomons GS; Brown MN; Schmidt MA; Roullet JB; Gibson KM
Pharmacol Res Perspect; 2019 Feb; 7(1):e00456. PubMed ID: 30631446
[TBL] [Abstract][Full Text] [Related]
3. Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicity.
Walters DC; Jansen EEW; Salomons GS; Arning E; Ashcraft P; Bottiglieri T; Roullet JB; Gibson KM
Epilepsy Res; 2021 Feb; 170():106536. PubMed ID: 33385945
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
[TBL] [Abstract][Full Text] [Related]
5. Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration.
Świąder MJ; Świąder K; Zakrocka I; Krzyżanowski M; Wróbel A; Łuszczki JJ; Czuczwar SJ
Pharmacol Rep; 2020 Apr; 72(2):322-330. PubMed ID: 32048251
[TBL] [Abstract][Full Text] [Related]
6. Vigabatrin-Induced Retinal Functional Alterations and Second-Order Neuron Plasticity in C57BL/6J Mice.
Chan K; Hoon M; Pattnaik BR; Ver Hoeve JN; Wahlgren B; Gloe S; Williams J; Wetherbee B; Kiland JA; Vogel KR; Jansen E; Salomons G; Walters D; Roullet JB; Gibson KM; McLellan GJ
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):17. PubMed ID: 32053727
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analysis in mice treated with vigabatrin identifies dysregulation of genes associated with retinal signaling circuitry.
Walters D; Vogel KR; Brown M; Shi X; Roullet JB; Gibson KM
Epilepsy Res; 2020 Oct; 166():106395. PubMed ID: 32679486
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical actions of vigabatrin and tiagabine alone and in combination in mouse cortex.
Leach JP; Sills GJ; Butler E; Forrest G; Thompson GG; Brodie MJ
Gen Pharmacol; 1997 May; 28(5):715-9. PubMed ID: 9184808
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
[TBL] [Abstract][Full Text] [Related]
10. Placental transfer of vigabatrin (gamma-vinyl GABA) and its effect on concentration of amino acids in the embryo of TO mice.
Abdulrazzaq YM; Padmanabhan R; Bastaki SM; Ibrahim A; Bener A
Teratology; 2001 Mar; 63(3):127-33. PubMed ID: 11283969
[TBL] [Abstract][Full Text] [Related]
11. Time course of the GABAergic effects of vigabatrin: is the time course of brain GABA related to platelet GABA-transaminase inhibition?
Valdizán EM; García AP; Armijo JA
Epilepsia; 1999 Aug; 40(8):1062-9. PubMed ID: 10448817
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic and mutagenic effects of vigabatrin, a γ-aminobutyric acid transaminase inhibitor, in Wistar rats submitted to rotarod task.
Coelho VR; Sousa K; Pires TR; Papke D; Vieira CG; de Souza LP; Leal MB; Schunck R; Picada JN; Pereira P
Hum Exp Toxicol; 2016 Sep; 35(9):958-65. PubMed ID: 26500220
[TBL] [Abstract][Full Text] [Related]
13. Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice.
Griffin WC; Nguyen SA; Deleon CP; Middaugh LD
Behav Pharmacol; 2012 Apr; 23(2):178-90. PubMed ID: 22336593
[TBL] [Abstract][Full Text] [Related]
14. Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.
Sills GJ; Patsalos PN; Butler E; Forrest G; Ratnaraj N; Brodie MJ
Neurology; 2001 Jul; 57(2):196-200. PubMed ID: 11468302
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin.
French JA
Epilepsia; 1999; 40 Suppl 5():S11-6. PubMed ID: 10530689
[TBL] [Abstract][Full Text] [Related]
16. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
Mattson RH; Petroff O; Rothman D; Behar K
Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
[TBL] [Abstract][Full Text] [Related]
18. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
Neal MJ; Shah MA
Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
[TBL] [Abstract][Full Text] [Related]
19. Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions.
Tran V; Hatalski CG; Yan XX; Baram TZ
Epilepsia; 1999 Sep; 40(9):1190-7. PubMed ID: 10487181
[TBL] [Abstract][Full Text] [Related]
20. Neurobehavioral effects of vigabatrin and its ability to induce DNA damage in brain cells after acute treatment in rats.
Sousa K; Decker N; Pires TR; Papke DK; Coelho VR; Pflüger P; Pereira P; Picada JN
Psychopharmacology (Berl); 2017 Jan; 234(1):129-136. PubMed ID: 27678549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
